That's where I run out of depth, to be perfectly honest. My staff have done their best to brief me and to put me in a position where I can carry on a reasonably superficial conversation about it. But basically, the message I want to leave is that the design of the ACR, as it's currently being put forward and currently being developed for introduction to the marketplace, is one that was soundly researched and validated to have a negative PCR or value on this dimension. It is not the same measure.
On June 5th, 2008. See this statement in context.